Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -CN¥44.62M, down 209.9% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CN¥44.62M | -209.9% |
| FY2024 | Dec 31, 2024 | CN¥40.60M | -41.1% |
| FY2023 | Dec 31, 2023 | CN¥68.90M | -18.6% |
| FY2022 | Dec 31, 2022 | CN¥84.63M | – |
See a number that looks wrong?